Aquestive Therapeutics Ownership | Who Owns Aquestive Therapeutics?


OverviewForecastRevenueFinancialsChartTranscripts

Aquestive Therapeutics Ownership Summary


Aquestive Therapeutics is owned by 47.62% institutional investors, 5.16% insiders, and 47.22% retail investors. Bratton capital management is the largest institutional shareholder, holding 10.77% of AQST shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.64% of its assets in Aquestive Therapeutics shares.

AQST Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockAquestive Therapeutics47.62%5.16%47.22%
SectorHealthcare Stocks 57.43%9.41%33.16%
IndustrySpecialty & Generic Drug Manufacturers Stocks25.54%11.10%63.36%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Bratton capital management9.81M10.77%$34.93M
Blackrock5.45M7.41%$14.18M
Blackrock funding, inc. /de6.00M6.59%$21.36M
Vanguard group4.35M4.77%$15.47M
Vr adviser2.63M2.89%$9.36M
Franklin resources2.13M2.34%$7.60M
Geode capital management1.65M1.82%$5.89M
Bioimpact capital1.61M1.77%$5.74M
State street1.50M1.65%$5.35M
Janney montgomery scott880.49K1.20%$2.29M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Bratton capital management9.81M100.00%$34.93M
Bioimpact capital1.61M0.81%$5.74M
Blue owl capital lp900.00K0.74%$3.20M
Latash investments243.13K0.68%$865.56K
Vr adviser2.63M0.64%$9.36M
Stonepine capital management160.00K0.46%$569.60K
Pale fire capital se525.76K0.42%$1.87M
Essex investment management623.31K0.40%$2.22M
Cahill wealth management143.05K0.26%$509.26K
Harvey capital management267.39K0.22%$951.91K

Top Buyers

HolderShares% AssetsChange
Blackrock5.45M0.00%4.11M
Goldman sachs group876.54K0.00%653.85K
Janney montgomery scott880.49K0.01%538.63K
Pale fire capital se525.76K0.42%501.76K
Morgan stanley555.99K0.00%463.06K

Top Sellers

HolderShares% AssetsChange
Vr adviser2.63M0.64%-2.93M
Laurion capital management lp---1.55M
Monashee investment management---1.00M
Invesco47.94K--738.63K
Ghost tree capital---702.94K

New Positions

HolderShares% AssetsChangeValue
Stonepine capital management160.00K0.46%160.00K$569.60K
Raymond james financial139.59K0.00%139.59K$497.67K
Moneco advisors43.90K0.02%43.90K$156.28K
Hrt financial lp42.18K0.00%42.18K$150.00K
State of wisconsin investment board25.01K0.00%25.01K$89.04K

Sold Out

HolderChange
National bank of canada /fi/-4.00
Coppell advisory solutions-16.00
True wealth design-47.00
Highmark wealth management-50.00
Northwestern mutual wealth management-50.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 2024117-4.10%43,374,494-7.27%471.81%66-15.38%3233.33%
Sep 30, 202412223.23%46,774,77210.17%511.54%7931.67%23-
Jun 30, 202499-3.88%42,456,8902.32%571.26%60-18.92%2364.29%
Mar 31, 202410368.85%41,494,84874.43%675.01%74131.25%147.69%
Dec 31, 20236117.31%23,788,7933.91%362.31%3268.42%13-

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv2.40M2.64%-
iShares Russell 2000 ETF1.94M2.13%-37.88K
Vanguard Institutional Extnd Mkt Idx Tr1.11M1.21%-
Invesco Dorsey Wright SmallCap Momt ETF775.69K0.85%1.41K
Fidelity Small Cap Index757.27K0.83%424.00
Nuveen Equity Index R6649.35K0.71%-
Franklin Biotechnology Discv A(acc)USD521.70K0.57%-821.40K
iShares Russell 2000 Value ETF498.91K0.55%-1.02K
MEDICAL BioHealth EUR Acc485.29K0.53%-
State St Russell Sm/Mid Cp® Indx NL Cl C432.58K0.47%-

Recent Insider Transactions


DateNameRoleActivityValue
Nov 26, 2024Jung Cassie Chief Operating OfficerSell$214.06
Mar 15, 2024Schobel Alexander Mark Chief Innovation/Tech OfficerSell$300.00K
Mar 08, 2024Schobel Alexander Mark Chief Innovation/Tech OfficerSell$129.69K
Jun 14, 2022Boyd Peter E. SVP-Bus. Process & Info. Tech.Buy$4.05K
Jun 08, 2022Barber Daniel Chief Executive OfficerBuy$88.07K

Insider Transactions Trends


DateBuySell
2025 Q1--
2024 Q4-1
2024 Q3--
2024 Q2--
2024 Q1-2

AQST Ownership FAQ


Who Owns Aquestive Therapeutics?

Aquestive Therapeutics shareholders are primarily institutional investors at 47.62%, followed by 5.16% insiders and 47.22% retail investors. The average institutional ownership in Aquestive Therapeutics's industry, Specialty & Generic Drug Manufacturers Stocks, is 25.54%, which Aquestive Therapeutics exceeds.

Who owns the most shares of Aquestive Therapeutics?

Aquestive Therapeutics’s largest shareholders are Bratton capital management (9.81M shares, 10.77%), Blackrock (5.45M shares, 7.41%), and Blackrock funding, inc. /de (6M shares, 6.59%). Together, they hold 24.77% of Aquestive Therapeutics’s total shares outstanding.

Does Blackrock own Aquestive Therapeutics?

Yes, BlackRock owns 7.41% of Aquestive Therapeutics, totaling 5.45M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 14.18M$. In the last quarter, BlackRock increased its holdings by 4.11M shares, a 305.59% change.

Who is Aquestive Therapeutics’s biggest shareholder by percentage of total assets invested?

Bratton capital management is Aquestive Therapeutics’s biggest shareholder by percentage of total assets invested, with 100.00% of its assets in 9.81M Aquestive Therapeutics shares, valued at 34.93M$.

Who is the top mutual fund holder of Aquestive Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Aquestive Therapeutics shares, with 2.64% of its total shares outstanding invested in 2.4M Aquestive Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools